Profile data is unavailable for this security.
About the company
ZYUS Life Sciences Corporation is a Canada-based life sciences company. The Company is focused on the global development and commercialization of cannabinoid-based pharmaceutical drug product candidates and exempt market therapeutics. Through clinical research, it is committed to furthering the understanding of cannabinoids with the clinical development of its pharmaceutical drug product candidates and intellectual property activities to protect its novel formulations. Additionally, the Company delivers cGMP / EU GMP-compliant cannabinoid products to patients through the exempt global medical market. The Company is also focused on commercialization of its exempt market therapeutics, such as cannabinoid oils, soft gel capsules and topical creams, in Canada and those international markets where medical cannabis is legal.
- Revenue in CAD (TTM)387.00k
- Net income in CAD-41.25m
- Incorporated1944
- Employees2.00
- LocationZYUS Life Sciences Corp204 - 407 Downey RoadSASKATOON S7N 4L8CanadaCAN
- Phone+1 (306) 242-2357
- Fax+1 (416) 368-4440
- Websitehttps://www.zyus.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Covalon Technologies Ltd | 26.24m | -2.77m | 49.88m | -- | -- | 2.48 | -- | 1.90 | -0.1123 | -0.1123 | 1.06 | 0.8021 | 1.02 | 1.84 | 4.53 | -- | -10.83 | -18.06 | -12.67 | -27.10 | 55.84 | 51.89 | -10.57 | -27.06 | 4.85 | -- | 0.0597 | -- | 46.56 | -0.096 | 51.79 | -- | 12.21 | -- |
KDA Group Inc | 186.28k | 133.66k | 49.99m | -- | 141.79 | 3.22 | 57.22 | 268.35 | 0.002 | 0.0926 | 0.0012 | 0.0886 | 0.0079 | -- | 0.0693 | -- | -0.4146 | -17.96 | -0.8534 | -44.69 | 36.51 | 26.76 | -52.24 | -28.00 | -- | -4.31 | 0.1287 | -- | -22.20 | -62.03 | 106.88 | -- | 31.67 | -- |
LSL Pharma Group Inc | 12.17m | -4.62m | 51.84m | -- | -- | 3.22 | -- | 4.26 | -0.056 | -0.056 | 0.1466 | 0.1489 | 0.3929 | 2.59 | 4.87 | -- | -14.92 | -- | -21.69 | -- | 19.76 | -- | -37.97 | -- | 0.4505 | -0.8465 | 0.4938 | -- | -- | -- | -- | -- | -- | -- |
Helix Biopharma Corp. | 0.00 | -5.65m | 58.83m | 9.00 | -- | -- | -- | -- | -0.0277 | -0.0277 | 0.00 | -0.0012 | 0.00 | -- | -- | 0.00 | -318.95 | -261.49 | -574.76 | -- | -- | -- | -- | -- | -- | -2,825.00 | -- | -- | -- | -- | 4.16 | -- | -28.36 | -- |
Simply Better Brands Corp | 95.08m | -30.01m | 59.65m | -- | -- | -- | -- | 0.6274 | -0.4156 | -0.4305 | 1.32 | -0.0854 | 2.71 | 12.68 | 17.69 | -- | -85.10 | -63.90 | -361.23 | -215.48 | 53.52 | -- | -31.40 | -29.46 | 0.2536 | -19.65 | 3.20 | -- | 22.08 | -- | -96.41 | -- | -- | -- |
Satellos Bioscience Inc | 0.00 | -21.13m | 60.91m | 12.00 | -- | 1.77 | -- | -- | -0.1718 | -0.1718 | 0.00 | 0.3059 | 0.00 | -- | -- | 0.00 | -93.29 | -107.22 | -109.86 | -136.58 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -40.33 | -- | 459.46 | -- |
Medmira Inc | 407.78k | -2.92m | 64.65m | 65.00 | -- | -- | -- | 158.54 | -0.0042 | -0.0042 | 0.0006 | -0.0229 | 0.0996 | 0.7899 | 0.3142 | -- | -71.41 | -69.95 | -- | -- | 61.54 | 66.76 | -717.02 | -187.61 | 0.1342 | -2.09 | -- | -- | -54.57 | -5.98 | -46.08 | -- | -- | -- |
Cannara Biotech Inc | 73.38m | 6.22m | 64.81m | -- | 10.36 | 0.8169 | 5.45 | 0.8832 | 0.0695 | 0.0695 | 0.8173 | 0.8814 | 0.5337 | 2.08 | 7.46 | -- | 4.52 | -4.46 | 6.23 | -4.95 | 10.06 | 17.86 | 8.48 | -15.88 | 0.3582 | -2.46 | 0.384 | -- | 59.91 | -- | 201.26 | -- | -- | -- |
ZYUS Life Sciences Corp | 387.00k | -41.25m | 73.68m | 2.00 | -- | 3.67 | -- | 190.39 | -0.5751 | -0.5751 | 0.0057 | 0.2833 | 0.0165 | -- | 0.7911 | -- | -175.44 | -57.88 | -242.41 | -71.19 | 46.25 | -16.16 | -10,658.40 | -10,367.37 | 0.315 | -7.99 | 0.3295 | -- | 17.79 | 213.99 | -72.73 | -- | -- | -- |
Theratechnologies Inc | 107.27m | -24.72m | 80.93m | 89.00 | -- | -- | -- | 0.7544 | -0.8509 | -0.8509 | 3.29 | -0.7349 | 1.03 | 1.89 | 7.81 | -- | -23.78 | -26.32 | -128.23 | -55.43 | 74.10 | 65.90 | -23.04 | -38.26 | 1.03 | -0.919 | 1.71 | -- | 2.13 | 12.58 | 49.28 | -- | -37.83 | -- |